Literature DB >> 7732899

Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue.

J Stjernschantz1, G Selén, B Sjöquist, B Resul.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7732899

Source DB:  PubMed          Journal:  Adv Prostaglandin Thromboxane Leukot Res        ISSN： 0732-8141


× No keyword cloud information.
  16 in total

Review 1.  Efficacy and adverse effects of medications used in the treatment of glaucoma.

Authors:  C B Camras; C B Toris; R R Tamesis
Journal:  Drugs Aging       Date:  1999-11       Impact factor: 3.923

2.  Effects on IOP restoration and blood-aqueous barrier after long-term treatment with latanoprost in open angle glaucoma and ocular hypertension.

Authors:  C Lindén; E Nuija; A Alm
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

3.  A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group.

Authors:  E P O'Donoghue
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

4.  Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.

Authors:  J P Nordmann; M Söderström; J F Rouland; F Malecaze
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 5.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

6.  Enhancement of scleral macromolecular permeability with prostaglandins.

Authors:  R N Weinreb
Journal:  Trans Am Ophthalmol Soc       Date:  2001

7.  Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.

Authors:  Li-chen Gao; Di Wang; Fang-qun Liu; Zheng-yu Huang; Hong-guang Huang; Gui-hua Wang; Xi Chen; Qun-zhi Shi; Li Hong; Li-ping Wu; Jie Tang
Journal:  Eur J Clin Pharmacol       Date:  2014-10-23       Impact factor: 2.953

Review 8.  Prostaglandin analogues in the treatment of glaucoma.

Authors:  C Lindén; A Alm
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

9.  Bimatoprost effects on aqueous humor dynamics in monkeys.

Authors:  David F Woodward; Achim H-P Krauss; Siv F E Nilsson
Journal:  J Ophthalmol       Date:  2010-05-23       Impact factor: 1.909

10.  Role of PKCepsilon in PGF2alpha-stimulated MMP-2 secretion from human ciliary muscle cells.

Authors:  Shahid Husain; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2008-06       Impact factor: 2.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.